New Peripheral Stent System

The stent is to be used in the treatment of atherosclerotic lesions in peripheral arteries below the aortic arch as well as in the palliative treatment of malignant neoplasms in the biliary duct.

Worldwide, around 60 million people have peripheral vascular disease (PVD), including those who are diabetic, obese, who smoke, have high blood pressure, have high cholesterol, or have a family history of coronary artery disease. This disease is caused by a build-up of fatty substances or plaques, which collect and adhere to the linings of blood vessels. Also, each year, thousands of patients are threatened by life-threatening blockages in the bile ducts. A biliary stent is often used to open the blockages so that fluids may continue to be transported to various organs such as the liver, gallbladder, and small intestines.

The Palmaz Blue stent features a closed cell design, tapered radial arcs, optimized struts and double Omega hinges that are designed to optimize fatigue life, maximize radial strength, and minimize foreshortening. The Palmaz Blue stent is the product of Cordis Endovascular (Warren, NJ, USA).

"With the European Launch of the Palmaz Blue stent, we are building on a proud legacy which began with the first Palmaz stent introduced in 1987 and more than 15 years of clinical history and long-term performance,” remarked Jack Springer, general manager, Cordis Endovascular.




Related Links:
Cordis Endovascular